期刊文献+
共找到1,640篇文章
< 1 2 82 >
每页显示 20 50 100
The Characteristics of Immunophenotype in Acute Lymphoblastic Leukemia and Its Clinical Significance 被引量:1
1
作者 舒文秀 陈燕 《The Chinese-German Journal of Clinical Oncology》 CAS 2005年第6期354-357,共4页
Objective: To study the characteristics of immunophenotype in acute lymphoblastic leukemia (ALL) and its clinical significance. Methods: Immunophenotyping was performed on 81 ALL patients by three-color flow cytom... Objective: To study the characteristics of immunophenotype in acute lymphoblastic leukemia (ALL) and its clinical significance. Methods: Immunophenotyping was performed on 81 ALL patients by three-color flow cytometry analysis using CD45/SSC gating, meanwhile the cytogenetic analysis was performed on 45 cases out of 81 ALL patients. Results: (1) CD19 was the most commonly expressed of all B-lineage antigens detected with the positive rate being 100%. In T-ALL, the positive expression rate of CD5 and CD7 was the highest, being 90%. Both B-ALL and T-ALL overlapped in expression of lineage antigens. There was no significant difference in the complete remission rate (CR rate) between T-ALL and B-ALL. (2) The incidence of ALL with rayeloid antigens expression (My+ALL) was 39.5%. CD13 was most often seen among the myeloid markers. My+ALL always involved in B-lineage antigens and the CR rate in children and adults was 72.2% and 78.6% respectively. (3) The incidence of HAL was 19.8%. Coexpression of B-lineage and myeloid-assoeiated antigens was the commonest subtype in HAL. The expression of CD34 was commonly seen in HAL patients (81.3%). The CR rate was low in HAL, 50% for children and 40% for adults. (4) Compared to T-ALL, B-ALL, My+ALL, and HAL had a higher positive rate of CD34 expression with the difference being significant (P〈0.025). Conclusion: Immunophenotyping had remarkable predominance in diagnosing special category of ALL (such as HAL and My+ALL); CD19 and CD5 were highly sensitive in diagnosing B-ALL and T-ALL, but less special, and overlapping was found in expression. No significant association was found between the expression of CD34 or myeloid antigens and CR rate, while low CR rate was found in HAL patients, especially for those coexpressing CD34 antigen. 展开更多
关键词 leukemia lymphoid cell acute immunophenotypE
暂未订购
儿童急性巨核细胞白血病免疫表型及遗传学分析
2
作者 姜柯安 傅国 +4 位作者 李婉清 舒逸 陈园园 牟琴 管贤敏 《实用医学杂志》 北大核心 2026年第3期470-476,共7页
目的分析急性巨核细胞白血病(AMKL)患儿免疫表型和遗传学特征,为临床诊断及治疗提供相关依据。方法回顾性分析2017年9月至2024年12月来院就诊的45例AMKL患儿的临床资料,其中男23例,女22例,包括唐氏综合征相关AMKL(DS-AMKL)患儿7例,non-D... 目的分析急性巨核细胞白血病(AMKL)患儿免疫表型和遗传学特征,为临床诊断及治疗提供相关依据。方法回顾性分析2017年9月至2024年12月来院就诊的45例AMKL患儿的临床资料,其中男23例,女22例,包括唐氏综合征相关AMKL(DS-AMKL)患儿7例,non-DS-AMKL患儿38例。应用流式细胞术进行免疫表型检测分析,G显带技术进行染色体核型分析,RT-PCR和测序技术进行融合基因检测分析。结果AMKL患儿初次就诊时最常见的临床表现为皮肤瘀斑或瘀点,中位数血小板17(3~222)×10^(9)/L。所有患儿骨髓幼稚细胞均至少表达血小板相关糖蛋白CD41a、CD42b和CD61中的一种,表达率最高的为CD41a(84.4%)。与non-DS-AMKL相比,DS-AMKL患儿中CD7、CD13、CD36有更高的检出率(P<0.05);而CD41a在non-DS-AMKL中有更高的检出率(P<0.05)。41例患儿进行了染色体核型分析,检出染色体异常33例(80.5%),其中复杂核型14例(34.1%)。21例non-DS-AMKL患儿进行了融合基因检测,检出6例CBFA2T3::GLIS2,2例NUP98::KDM5A,NUP98::ING4、RBM15::MKL1和KMT2A::MLLT3各1例。CBFA2T3::GLIS2阳性患儿具有特征性的免疫表型,即都高表达CD56,不表达HLA-DR和CD36。结论儿童AMKL是一类高度异质性的疾病,具有相对特征性的免疫表型,染色体异常率高,最常见的融合基因为CBFA2T3::GLIS2。通过免疫表型和遗传学致病分子检测及分析,能够提高对AMKL的识别和诊断,更好地进行预后分层和选择治疗方案。 展开更多
关键词 急性巨核细胞白血病 免疫表型 染色体 融合基因
暂未订购
类似于卵巢性索肿瘤的子宫肿瘤临床病理及分子遗传学特征分析
3
作者 段亚伟 王铭 +2 位作者 王国庆 沈杨 张丽华 《实用妇产科杂志》 北大核心 2026年第1期53-58,共6页
目的:探讨类似于卵巢性索肿瘤的子宫肿瘤(UTROSCT)的临床病理特征及分子遗传学特征。方法:回顾性分析9例UTROSCT的临床病理特征,并应用免疫组化方法、RNA测序和荧光原位杂交技术检测相关基因改变。结果:9例患者的发病年龄为25~68岁,平均... 目的:探讨类似于卵巢性索肿瘤的子宫肿瘤(UTROSCT)的临床病理特征及分子遗传学特征。方法:回顾性分析9例UTROSCT的临床病理特征,并应用免疫组化方法、RNA测序和荧光原位杂交技术检测相关基因改变。结果:9例患者的发病年龄为25~68岁,平均48.2岁。除1例术前临床诊断为子宫内膜癌伴神经内分泌分化外,其余8例术前临床诊断均为子宫平滑肌瘤。6例具有GREB1、ESR1、NCOA1/2/3基因重排,3例检测出其他基因重排。GREB1重排患者的平均年龄(58.3岁)显著大于非GREB1重排患者(40.2岁)。GREB1重排肿瘤常位于子宫内膜/内膜下。镜下ESR1重排肿瘤比GREB1重排肿瘤更常表现为经典性索样形态。肿瘤细胞表达性索、平滑肌和上皮免疫标志。2例复发/转移肿瘤中,其中1例伴GREB1重排。结论:UTROSCT大部分为良性肿瘤,只有小部分表现出临床侵袭性行为。伴GREB1重排的肿瘤年龄较大,更易复发或转移。UTROSCT临床诊断困难,应完善GREB1、ESR1等基因检测,并加强伴GREB1重排患者的临床管理。 展开更多
关键词 类似于卵巢性索肿瘤的子宫肿瘤 临床病理特征 免疫表型 分子遗传学 预后
暂未订购
成熟T细胞淋巴瘤与意义未明克隆性T细胞的免疫表型及临床生物学特点分析
4
作者 李曌博 程薇 +4 位作者 黄洲风 于润红 窦蕊 李威 朱尊民 《中国实验血液学杂志》 北大核心 2026年第1期92-98,共7页
目的:分析成熟T细胞淋巴瘤(TCL)和意义未明的克隆性T细胞(T-CUS)的免疫表型及临床特点,探索流式细胞术在TCL与T-CUS鉴别诊断中的应用价值。方法:通过多参数流式细胞术(MFC)分析并比较2019年10月至2024年6月河南省人民医院血液科收治的93... 目的:分析成熟T细胞淋巴瘤(TCL)和意义未明的克隆性T细胞(T-CUS)的免疫表型及临床特点,探索流式细胞术在TCL与T-CUS鉴别诊断中的应用价值。方法:通过多参数流式细胞术(MFC)分析并比较2019年10月至2024年6月河南省人民医院血液科收治的93例TCL患者(TCL组)、46例检测出反应性克隆性T淋巴细胞患者(T-CUS组)的免疫表型特征,同时收集TCL组与T-CUS组患者的临床及实验室资料。结果:流式流式细胞术检测结果显示,TCL组与T-CUS组患者具有相似的免疫表型,均以CD8^(+)异常表型T细胞最多,CD4^(+)次之,CD4^(+)/CD8^(+)双阳性和CD4^(-)/CD8^(-)双阴性罕见。两组CD3、CD4、CD8的阳性表达率具有明显的统计学差异,TCL组患者的CD3表达率(72.00±42.04)和CD8表达率(56.04±48.22)低于T-CUS组(94.05±21.61,79.86±36.33,P<0.05),而CD4表达率(38.35±48.53)则高于T-CUS组(10.76±31.15)(P<0.01)。TRBC1在所有TCL和T-CUS病例中均呈限制性表达模式,TCL组TRBC1阳性表达率略高于T-CUS组,但两者之间差异无显著统计学意义(P>0.05)。TCL组患者的红细胞平均分布宽度(RDW-CV)和血清乳酸脱氢酶(LDH)水平分别为17.6(11.9-24)、459(129-90704),均明显高于T-CUS组的14.1(10.9-19.1)、310(99-11722)(P<0.05)。统计两组病例可获得的TCR基因重排结果,用Kappa检验统计分析,结果显示,TCL组TCR基因重排阳性率(92.1%)明显高于T-CUS组(52.6%),且差异有统计学意义(P<0.001)。结论:TRBC1可以作为快速检测T细胞克隆性的理想指标,MFC联合TCR基因重排检查对鉴别TCL和T-CUS有较好的临床价值。 展开更多
关键词 TCRβ链恒定区结构域蛋白 T细胞淋巴瘤 意义未明的克隆性T细胞 免疫表型 流式细胞术
原文传递
血清IL-15、MMP-2水平与儿童急性淋巴细胞白血病免疫分型和预后的关系
5
作者 黄莎莎 张瀚月 +1 位作者 陈兰兰 郑莉 《成都医学院学报》 2026年第1期152-156,共5页
目的研究血清白介素15(IL-15)、基质金属蛋白酶2(MMP-2)水平与儿童急性淋巴细胞白血病(ALL)免疫分型和预后的关系。方法选取2018年7月至2021年8月在山东第一医科大学附属省立医院就诊的ALL患儿154例为白血病组,根据免疫分型分为早期前B-... 目的研究血清白介素15(IL-15)、基质金属蛋白酶2(MMP-2)水平与儿童急性淋巴细胞白血病(ALL)免疫分型和预后的关系。方法选取2018年7月至2021年8月在山东第一医科大学附属省立医院就诊的ALL患儿154例为白血病组,根据免疫分型分为早期前B-ALL组(112例)、前B-ALL组(29例)和成熟B-ALL组(13例)。另选取同期在该院体检的154例健康儿童作为对照组。检测血清IL-15、MMP-2水平;收集白血病组临床资料;随访并统计白血病组患儿的生存情况;采用多因素Cox回归分析白血病组患儿死亡的影响因素;采用Kaplan-Meier法分析血清IL-15、MMP-2表达水平对白血病组患儿生存率的影响。结果与对照组相比,白血病组血清IL-15水平降低,MMP-2水平升高(P<0.05)。早期前B-ALL组、前B-ALL组、成熟B-ALL组血清IL-15水平依次降低,血清MMP-2水平依次升高(P<0.05)。死亡组患儿有微小残留病变、有MLL基因重排所占比例和血清MMP-2高于生存组患儿,血清IL-15低于生存组患儿(P<0.05)。IL-15低表达患儿的生存率低于IL-15高表达患儿(62.32%vs 80.00%,P<0.05),MMP-2高表达患儿的生存率低于MMP-2低表达患儿(63.01%vs 80.25%,P<0.05)。有微小残留病变(HR=2.476)、有MLL基因重排(HR=2.069)、低水平IL-15(HR=0.462)以及高水平MMP-2(HR=2.855)是ALL患儿死亡的影响因素(P<0.05)。结论ALL患儿血清IL-15水平较低,MMP-2水平较高,与免疫分型和预后生存有关。 展开更多
关键词 急性淋巴细胞白血病 免疫分型 预后 白介素15 基质金属蛋白酶2
暂未订购
CD5阳性弥漫大B细胞淋巴瘤分子生物学研究进展
6
作者 马梦雨 朱尊民 《临床血液学杂志》 2026年第1期101-106,共6页
CD5阳性弥漫大B细胞淋巴瘤(CD5 positive diffuse large B-cell lymphoma,CD5^(+)DLBCL)是DLBCL的一种独特亚型,具有高度侵袭性,常表现为体能状态较差、乳酸脱氢酶升高、高龄(>60岁)、女性、结外受累多见,与DLBCL非特指型比较预后较... CD5阳性弥漫大B细胞淋巴瘤(CD5 positive diffuse large B-cell lymphoma,CD5^(+)DLBCL)是DLBCL的一种独特亚型,具有高度侵袭性,常表现为体能状态较差、乳酸脱氢酶升高、高龄(>60岁)、女性、结外受累多见,与DLBCL非特指型比较预后较差。研究显示,即使经过R-CHOP治疗,仍有40%左右的患者出现复发或难治,中枢神经系统复发率也更高。近年来,针对CD5^(+)DLBCL在遗传学和生物学方面不断进行探索,加深了人们对CD5^(+)DLBCL的认识,促进了更多有效的方案应用于CD5^(+)DLBCL的治疗中。文章主要对近年来CD5^(+)DLBCL的免疫表型特点、基因及染色体特征的研究进展进行综述。 展开更多
关键词 CD5阳性弥漫大B细胞淋巴瘤 免疫表型 遗传学
原文传递
Immunophenotyping of Lymphocyte T and B in the Peripheral Blood of Systemic Lupus Erythematosus 被引量:11
7
作者 胡绍先 陶德定 何培根 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2001年第2期108-109,共2页
The immunophenotyping expression levels of lymphocyte in the peripheral blood from 21 patients with active systemic lupus erythematosus were analyzed by using the immunofluorescence labeling flow cytometry technique... The immunophenotyping expression levels of lymphocyte in the peripheral blood from 21 patients with active systemic lupus erythematosus were analyzed by using the immunofluorescence labeling flow cytometry technique to investigate the immunophenotyping expression of lymphocytes T and B in the peripheral blood of active SLE patients and its clinical value. It was showed that, compared with normal controls, the expression of CD + 3, CD + 4 and the ratio of CD + 4/CD + 8 in the peripheral blood of these patients were decreased , while the expression of CD + 8, CD + 20 was significantly increased . It was suggested that both T and B cells in patients with active SLE involved in immunoregulation, were activated. The abnormal expression of lymphocyte immunophenotyping could influence the immune reaction in SLE patients, which might be one of the important pathogenesis factors in SLE. 展开更多
关键词 systemic lupus erythematosus immunophenotypING
暂未订购
Immunophenotype and differentiation capacity of bone marrow-derived mesenchymal stem cells from CBA/Ca,ICR and Balb/c mice 被引量:4
8
作者 Yin Yin Ooi Zul'atfi Rahmat +2 位作者 Shinsmon Jose Rajesh Ramasamy Sharmili Vidyadaran 《World Journal of Stem Cells》 SCIE CAS 2013年第1期34-42,共9页
AIM:To assess the capacity to isolate and expand mesenchymal stem cells(MSC)from bone marrow of CBA/Ca,ICR and Balb/c mice. METHODS:Bone marrow of tibia and femur were flushed,cultured and maintained in supplemented D... AIM:To assess the capacity to isolate and expand mesenchymal stem cells(MSC)from bone marrow of CBA/Ca,ICR and Balb/c mice. METHODS:Bone marrow of tibia and femur were flushed,cultured and maintained in supplemented Dulbecco’s modified Eagle’s medium.MSC immunophenotype of cultures were tracked along increasing passages for positivity to CD106,Sca-1 and CD44 and negativity to CD45,CD11b and MHC classⅡ.Differentiation capacity of MSC towards osteogenic and adipo-genic lineages were also assessed. RESULTS:MSC were successfully cultured from bone marrow of all 3 strains,albeit differences in the temporal expression of certain surface antigens.Their differentiation into osteocytes and adipocytes were also observed. MSC from all 3 mouse strains demonstrated a shift from a haematopoietic phenotype(CD106-CD45+CD11b+Sca-1low)to typical MSC phenotype(CD106+CD45-CD11b-Sca-1high)with increasing passages. CONCLUSION:Information garnered assists us in the decision of selecting a mouse strain to generate MSC from for downstream experimentation. 展开更多
关键词 Mesenchymal stem cells Mouse bone MARROW CBA/Ca STRAIN ICR STRAIN BALB/C STRAIN immunophenotypING Differentiation
暂未订购
Immunophenotypic signature of primary glioblastoma multiforme: A case of extended progression free survival 被引量:2
9
作者 Puneet Gandhi Richa Khare +1 位作者 Nitin Garg Sandeep Sorte 《World Journal of Clinical Cases》 SCIE 2017年第6期247-253,共7页
Glioblastoma-multiforme(GBM), the most aggressive glial tumor, has a worldwide age-adjusted incidence ranging from 0.59-3.69/100000 persons. Despite current multimodal-treatment approach, median-survival time and prog... Glioblastoma-multiforme(GBM), the most aggressive glial tumor, has a worldwide age-adjusted incidence ranging from 0.59-3.69/100000 persons. Despite current multimodal-treatment approach, median-survival time and progression-free survival(PFS) remains short. Glioblastomas display a variety of molecular alterations, which necessitates determining which of these have a prognostic significance. This is a case of a 45-yearold patient who presented with progressive slurring of speech and features of raised intracranial pressure. Computed tomography(CT) scan revealed a large heterogeneously enhancing lesion in the left front-temporalperisylvian region with solid, cystic areas, suggestive of malignant glioma. Partial tumor-excision was followed by concurrent chemo-radiotherapy. Histopathologically, the tumor was astrocytoma grade-IV. Patient had an extended PFS of 12 mo, with an overall survival of 26 mo. Primary-GBM was confirmed using molecular markers and the immunophenotypic signature was defined by evaluating systemic expression of human telomerase reverse transcriptase, interleukin-6, neutrophil-lymphocyte ratio, tissue inhibitor of metalloproteinases-1, human chitinase-3-like-protein-1(YKL-40) and high mobility group-A1. Current findings suggest that this signature can identify worst outcomes, independent of clinical criteria. 展开更多
关键词 GLIOBLASTOMA MULTIFORME immunophenotypic SIGNATURE Progression free survival Molecular markers Human TELOMERASE reverse transcriptase INTERLEUKIN-6 Tissue inhibitor of metalloproteinases-1 YKL-40 High mobility group-A1
暂未订购
Immunophenotyping of hematopoietic progenitor cells: Comparison between cord blood and adult mobilized blood grafts 被引量:1
10
作者 Nesrine Ben Azouna Faouzi Jenhani +1 位作者 Lamia Berraeis Zohra Regaya 《World Journal of Stem Cells》 SCIE CAS 2011年第11期104-112,共9页
AIM:To study the immunophenotype of hematopoietic progenitor cells from cord blood (CB) grafts (n = 39) in comparison with adult apheresis grafts (AG, n = 229) and pre-apheresis peripheral blood (PAPB) samples (n = 90... AIM:To study the immunophenotype of hematopoietic progenitor cells from cord blood (CB) grafts (n = 39) in comparison with adult apheresis grafts (AG, n = 229) and pre-apheresis peripheral blood (PAPB) samples (n = 908) using flow cytometry analysis.METHODS: First, we performed a qualitative analysis of CD34+ cell sub-populations in both CB and PAPB grafts using the standardized ISHAGE protocol and a wide panel of 20 monoclonal antibodies. Next, we stud-ied some parameters, such as the age of mothers and the weight of newborns, which can influence the qual-ity and the quantity of CD34+ cells from CB. RESULTS: We found that the percentage of apoptotic cells was high in CB in comparison to PAPB (PAPB: 4.6% ± 2.6% vs CB: 53.4% ± 5.2%, P < 0.001). In CB, the weight of newborn and the age of the mother have the influence on CD34+ cells. The follow-up of Ag CD133in the ISHAGE double platform protocol in association with CD45, CD34 and the 7’AAD shows an equal rate between the two cell populations CD133+CD45+CD34+ high and CD34+CD45+ high with a higher percentage. So, is the inclusion of Ac CD133 necessary in the pres-ent panel included in the ISHAGE methodflLast part, we showed a signif icant presence of interferon γ in CB in comparison to PAPB, the annexin showing the high number of apoptotic cells in CB. CONCLUSION: This study demonstrates that many different obstetric factors must be taken into account when processing and cryo-banking umbilical CB units for transplantation. 展开更多
关键词 immunophenotypING HEMATOPOIETIC pro- genitor CORD BLOOD Mobilized BLOOD
暂未订购
Effects of DDPH on HECCM-induced Proliferation and Immunophenotypes of the Pulmonary Vascular Pericytes 被引量:1
11
作者 袁永辉 车东媛 熊密 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2001年第3期184-187,共4页
In order to study the effects of 1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino) propane hydrochloride (DDPH) on proliferation and immunophenotypes of newborn rat pulmonary vascular pericytes induced by hypo... In order to study the effects of 1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino) propane hydrochloride (DDPH) on proliferation and immunophenotypes of newborn rat pulmonary vascular pericytes induced by hypoxic endothelial cell conditioned medium (HECCM) from porcine pulmonary arteries, the cultured pericytes were divided into 4 groups according to the endothelial cell conditioned medium (ECCM) used: normoxic ECCM (NECCM) group, NECCM+DDPH group, HECCM group and HECCM+DDPH group. Cell culture, immunocytochemical staining, image analysis and flow cytometric method were used to investigate the effects of HECCM and DDPH on the expression of α-smooth muscle actin (α-SM-Actin) antigen, CD34 antigen, S-100 antigen and proliferating cell nuclear antigen (PCNA) and cell cycle in pericytes. The results showed that the α-SM-Actin antigen in the pericytes in HECCM group was stronger positively expressed than in the other three groups, but CD34 antigen and S-100 antigen were negatively expressed. The expression of α-SM-Actin antigen, CD34 antigen and S-100 antigen was positive in the groups of NECCM, NECCM+DDPH and HECCM+DDPH; The expression of α-SM-Actin and PCNA in HECCM group was 1.32 times (P<0.01) and 1.24 times (P<0.05) that in NECCM group, 1.30 times (P<0.01) and 1.21 times (P<0.05) that in HECCM+DDPH group, respectively. The percentage of the cells in the GO-G1 phase in the HECCM group was lower by 11.7 % and 9.1 %, in S phase higher by 5.6 % and 4.2 %, in G2-M phase higher by 6.1 % and 4.9 % than in the groups of NECCM,HECCM+DDPH, respectively. The inhibitory rate of DDPH on the increased α-SM-Actin and PCNA syntheses in pericytes induced by HECCM were 23.4 % and 17.1 % respectively. The inhibitory rate on the increased pericytes from GO-G1 phase to S phase was 8.3 %. These results suggest that DDPH can directly inhibit pericytes from proliferation and immunophenotypical transformation of smooth muscle-like cells induced by HECCM. 展开更多
关键词 DDPH PERICYTE immunophenotypes HECCM hypertension pulmonary
暂未订购
Immunophenotypings of Malignant Epithelial Mesothelioma and Their Roles in the Differential Diagnosis
12
作者 阮秋蓉 胡余昌 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2004年第2期112-115,共4页
To investigate the immunophenotypings of malignant epithelial mesothelioma (MEM), and to seek the valuable markers in distinguishing peritoneal MEM from peritoneal metastatic ovarian adenocarcinoma (OA) and colorectal... To investigate the immunophenotypings of malignant epithelial mesothelioma (MEM), and to seek the valuable markers in distinguishing peritoneal MEM from peritoneal metastatic ovarian adenocarcinoma (OA) and colorectal adenocarcinoma (CA), immunohistochemical SP method was used to detect expressions of HBME-1, E-cadherin, CA19-9, MOC-31 and CK7 in paraffin-embedded tissues of 18 cases of MEM, 20 OA and 20 CA. The results showed that there was a significant difference in the expressions of E-cadherin, CA19-9 and MOC-31 between MEM and OA group (P<0.05). Similarly, the difference in the expression of HBME-1, E-cadherin, CA19-9, MOC-31 and CK7 between MEM and CA groups is significant (P<0.05). These results indicate that HBME-1 could be used as a positive marker in distinguishing MEM from CA. E-cadherin, CA19-9 and MOC-31 are considered to be useful negative markers in diagnostic distinction between MEM and metastatic adenocarcinomas, including OA and CA. CK7 is the best positive marker in distinguishing MEM from CA, but this marker appears to be valueless in discriminating MEM from OA. 展开更多
关键词 malignant mesothelioma metastatic adenocarcinoma immunophenotypING HBME-1 E-cadherin CA19-9 MOC-31 CK7
暂未订购
Immunophenotype and Ultrastructure of B-cell Lymphoproliferative Disorder with Cytoplasmic Projection
13
作者 刘新月 胡闲石 +1 位作者 樊丽华 阮幼冰 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2003年第3期236-238,共3页
To identify the knowledge of rare lymphoproliferative disorder, the clinical and biological features of three kinds of lymphoproliferative disorders with cytoplasmic projections were compared The clinical manifestat... To identify the knowledge of rare lymphoproliferative disorder, the clinical and biological features of three kinds of lymphoproliferative disorders with cytoplasmic projections were compared The clinical manifestations, ultrastructure and immunophenotype were analyzed The results showed that hairy cell leukemia (HCL), splenic lymphoma with villous lymphocyte (SLVL) and hairy cell leukemia-variant (HCL-V) had some common characters including splenomegaly, peripheral blood and bone marrow infiltration by villous lymphocyte and B lymphocyte immunophenotype; but these three disorders had specific features respectively It was concluded that overall analysis of clinical and laboratory features might be contributive to the differential diagnosis of these three disorders 展开更多
关键词 lymphoproliferative disorder hairy cell immunophenotypING electron microscopy
暂未订购
Immunophenotypic characteristics of multipotent mesenchymal stromal cells that affect the efficacy of their use in the prevention of acute graft vs host disease
14
作者 Nataliya Petinati Nikolay Kapranov +7 位作者 Yulia Davydova Alexey Bigildeev Olesya Pshenichnikova Dmitriy Karpenko Nina Drize Larisa Kuzmina Elena Parovichnikova Valeriy Savchenko 《World Journal of Stem Cells》 SCIE 2020年第11期1377-1395,共19页
BACKGROUND Multipotent mesenchymal stromal cells(MSCs)are widely used in the clinic due to their unique properties,namely,their ability to differentiate in all mesenchymal directions and their immunomodulatory activit... BACKGROUND Multipotent mesenchymal stromal cells(MSCs)are widely used in the clinic due to their unique properties,namely,their ability to differentiate in all mesenchymal directions and their immunomodulatory activity.Healthy donor MSCs were used to prevent the development of acute graft vs host disease(GVHD)after allogeneic bone marrow transplantation(allo-BMT).The administration of MSCs to patients was not always effective.The MSCs obtained from different donors have individual characteristics.The differences between MSC samples may affect their clinical efficacy.AIM To study the differences between effective and ineffective MSCs.METHODS MSCs derived from the bone marrow of a hematopoietic stem cells donor were injected intravenously into allo-BMT recipients for GVHD prophylaxis at the moment of blood cell reconstitution.Aliquots of 52 MSC samples that were administered to patients were examined,and the same cells were cultured in the presence of peripheral blood mononuclear cells(PBMCs)from a third-party donor or treated with the pro-inflammatory cytokines IL-1β,IFN and TNF.Flow cytometry revealed the immunophenotype of the nontreated MSCs,the MSCs cocultured with PBMCs for 4 d and the MSCs exposed to cytokines.The proportions of CD25-,CD146-,CD69-,HLA-DR-and PD-1-positive CD4+and CD8+cells and the distribution of various effector and memory cell subpopulations in the PBMCs cocultured with the MSCs were also determined.RESULTS Differences in the immunophenotypes of effective and ineffective MSCs were observed.In the effective samples,the mean fluorescence intensity(MFI)of HLAABC,HLA-DR,CD105,and CD146 was significantly higher.After MSCs were treated with IFN or cocultured with PBMCs,the HLA-ABC,HLA-DR,CD90 and CD54 MFI showed a stronger increase in the effective MSCs,which indicated an increase in the immunomodulatory activity of these cells.When PBMCs were cocultured with effective MSCs,the proportions of CD4+and CD8+central memory cells significantly decreased,and the proportion of CD8+CD146+lymphocytes increased more than in the subpopulations of lymphocytes cocultured with MSC samples that were ineffective in the prevention of GVHD;in addition,the proportion of CD8+effector memory lymphocytes decreased in the PBMCs cocultured with the effective MSC samples but increased in the PBMCs cocultured with the ineffective MSC samples.The proportion of CD4+CD146+lymphocytes increased only when cocultured with the inefficient samples.CONCLUSION For the first time,differences were observed between MSC samples that were effective for GVHD prophylaxis and those that were ineffective.Thus,it was shown that the immunomodulatory activity of MSCs depends on the individual characteristics of the MSC population. 展开更多
关键词 Multipotent mesenchymal stromal cells Acute graft vs host disease immunophenotypE LYMPHOCYTES IMMUNOMODULATION Pro-inflammatory cytokines
暂未订购
IMMUNOPHENOTYPING OF CUTANEOUS GERMINAL CENTER CELL-DERIVED LYMPHOMAS
15
作者 许良中 邱丙森 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 1989年第1期64-68,共5页
Monoclonal antibodies were used to label cutaneous germinal center cell-derived lymphomas <CGCCL) obtained from 10 patients. According to the Kiel classification, they were classified into 2 types. Eight patients h... Monoclonal antibodies were used to label cutaneous germinal center cell-derived lymphomas <CGCCL) obtained from 10 patients. According to the Kiel classification, they were classified into 2 types. Eight patients had centroblastic/centrocytic <CB/CC) lymphomas while 2 patients and centrocytic (CC) lymphomas. After monoclonal antibody labelling, the results were consistent with those of the clinical and morphologic analyses. Of the 10 cases, 9 were B1 positive, 6 were K positive, and 4 were λ positive. In 8 cases labeled with immunoglobulin, 6 were IgGFab positive, 2 were IgM positive and 8 were IgA negative. Five cases (CB/CC 3, CC 2) were both Bl, K and IgG positive (γ K). Four cases CB/CC were both Bl and A positive. Only one case (CB/CC) was both K and IgM positive (μ K). Two cases (CB CC) were both A and IgG positive (γ λ). The results indicate that Bl, K and A are the most important markers to phenotype cutaneous B-cell lymphomas. Our findings also show a higher percentage of y K types in CGCCL as compared with Western countries. 展开更多
关键词 immunophenotypING OF CUTANEOUS GERMINAL CENTER CELL-DERIVED LYMPHOMAS CB
暂未订购
Application of Flow Cytometry in Examination of Immunophenotypes in Human Cells
16
作者 Zebo HUANG Aoxiang FENG +2 位作者 Yuhan SHI Haoxian WANG Guanghong WU 《Agricultural Biotechnology》 CAS 2022年第6期145-148,共4页
[Objectives]This study was conducted to establish a method for detecting the immunophenotypes of venous blood CIK cells in healthy donors and patients with triple-negative breast cancer or lung cancer by flow cytometr... [Objectives]This study was conducted to establish a method for detecting the immunophenotypes of venous blood CIK cells in healthy donors and patients with triple-negative breast cancer or lung cancer by flow cytometry,and to further analyze and discuss the proportion of cellular immunophenotypes such as CD3^(+),CD4^(+),CD8^(+),CD3^(+)CD8^(+),CD3^(+)CD56^(+)in CIK cells.[Methods]Human venous blood was drawn,then anticoagulated with heparin and isolated with lymphocyte isolation solution,and the relevant immunophenotypes were detected by flow cytometry after 21 d of culture.[Results]The expression of CD3^(+)CD8^(+)and CD3^(+)CD56^(+)in the venous blood CIK cells was significantly higher in healthy donors than that in triple-negative breast and lung cancer patients.[Conclusions]CD3^(+)CD8^(+)and CD3^(+)CD56^(+)CIK cells have high anti-tumor activity. 展开更多
关键词 Flow cytometry immunophenotypE Cluster of differentiation CIK
暂未订购
Association of Morphology and Immunophenotype in Diffuse Large B-Cell Lymphomas with Bone Marrow Infiltration in a Sample Mexican Population
17
作者 Mónica-Belinda Romero-Guadarrama Fiacro Jiménez Ponce +2 位作者 Armando Medina Cruz Elsa Lorena Durán Ramírez Icela Palma Lara 《Open Journal of Pathology》 2012年第2期29-37,共9页
Introduction: Diffuse large B-cell lymphoma (DLBCL), not otherwise specified, is a large B-cell lymphoma with a diffuse growth pattern and aggressive clinical course. It is divided in subgroups according to its morpho... Introduction: Diffuse large B-cell lymphoma (DLBCL), not otherwise specified, is a large B-cell lymphoma with a diffuse growth pattern and aggressive clinical course. It is divided in subgroups according to its morphology, immunophenotype, and primary site. Dissemination to bone marrow occurs in 11% to 35% of cases and can be of concordant or discordant morphology. Objective: To examine the association, the type of bone marrow involvement in relation to the primary site, morphology, immunohistochemistry of DLBCLs and to determine the cases of Epstein-Barr virus positive DLBCLs. Materials and Methods: We reviewed lymph node and extranodal biopsies as well as the respective bone marrow biopsies in all cases of DLBCL diagnosed in the Hospital General de México during the period from 2002 to 2010. We used immunohystochemistry for immunophenotype identification (Hans’s algorithm) and an in-situ hybridization technique to detect presence of Epstein Barr encoded RNA (EBER). Results: We included 108 patients with a mean age of 51.9 years, 59 (55%) were men. DLBCL involved lymph nodes in 60% of cases and palatine tonsils in 13%. The centroblastic variant predominated (80%) and 58% originated from activated B-cells. Infiltration of bone marrow was present in 30% of cases and was discordant in 55% of these cases. Correlation between morphology and bone marrow infiltration was statistically significant (P = 0.0003). Presence of Epstein-Barr virus was demonstrated in 15% of patients older than 50 years. Conclusions: Dissemination to bone marrow occurred in 30% of cases and discordant involvement was most common. DLBCL originating from activated B-lymphocytes predominated and the most common extranodal sites were palatine tonsils, suggesting that our population has a clinical behavior similar to Asiatic populations. 展开更多
关键词 DISSEMINATION to Bone MARROW Diffuse Large B-CELL LYMPHOMA immunophenotypE
暂未订购
Validation and quality control of hematolymphoid neoplasm immunophenotyping by flow cytometry
18
作者 Wu Lijuan Xu Dongsheng 《国际检验医学杂志》 CAS 2012年第23期2852-2858,共7页
cytometric immunophenotyping has evolved from two-parameter quantitative measurement of peripheral blood lymphocytes to five-or more parameter qualitative evaluation of bone marrow for hematopathology.Leukemia/lymphom... cytometric immunophenotyping has evolved from two-parameter quantitative measurement of peripheral blood lymphocytes to five-or more parameter qualitative evaluation of bone marrow for hematopathology.Leukemia/lymphoma immunophenotyping represent an important addition to histomorphology in the diagnosis,classification and monitoring of hematolymphoid neoplasms.The complexity of five-or more parameter analyses and the interpretation of the data rely on standardization and validation of the instrument,the reagent and the procedure.In addition,clinical flow cytometry laboratories in U.S.are required to document proficiency testing,sample preparation,method accuracy,specificity,sensitivity and precision.CLSI and the U.S.-Canadian Consensus Conference have provided recommendations,but each laboratory is responsible for validating its own qualitative and quantitative procedures.This paper introduces the procedures for quality control of all levels of the operation in a clinical flow cytometry laboratory in USA. 展开更多
关键词 英文摘要 编辑工作 学术论文 期刊
在线阅读 下载PDF
Flowcytometric detection of immunoglobulinlight chain in hematolymphoid immunophenotyping
19
作者 Xu Dongsheng 《国际检验医学杂志》 CAS 2011年第15期1696-1700,共5页
During B-cell development and maturation,the antigen receptor,which is encoded by the immunoglobulin heavy-(IgH) and light-chain genes,rearrange to associate one of a number of variable,diverse,and joining gene segmen... During B-cell development and maturation,the antigen receptor,which is encoded by the immunoglobulin heavy-(IgH) and light-chain genes,rearrange to associate one of a number of variable,diverse,and joining gene segments.A single mature B-cell expresses an IgH chain and either a kappa or lambda light chain,which is known as allelic or isotypic exclusion.In normal or reactive conditions,lymphoid cells comprise the mixtures of lymphocytes with either kappa or lambda expression. 展开更多
关键词 摘要 编辑部 编辑工作 读者
在线阅读 下载PDF
The immunophenotypic changes and clinical effectiveness after treatment of cancer patients with infusion of human peripheral blood lymphocytes stimulated by anti-CD28 and anti-CD80 monoclonal antibodies in combination with radiotherapy and chemotherapy
20
作者 JUN JIA LI QIONG LUO +4 位作者 XUE LING RUAN QI FENG CHENG LIAN HUA XIONG TONG WANG SHU LIN HUANG 《Journal of Microbiology and Immunology》 2005年第2期142-147,共6页
To investigate the changes on the immunopbenotypes and the clinical effects of treatment of the late cancer patients with infusion of human peripheral blood lymphocytes stimulated by anti-CD28 and anti-CD80 monoclonal... To investigate the changes on the immunopbenotypes and the clinical effects of treatment of the late cancer patients with infusion of human peripheral blood lymphocytes stimulated by anti-CD28 and anti-CD80 monoclonal antibodies in combination with radiotherapy and chemotherapy, 42 patients with late cancers were collected for study, among which 22 patients were treated with infusion of stimulated lymphocytes in combination with radiotherapy and chemotherapy. The immunological treatment procedure was given twice per week, and one course of treatment consisted of 8 times of giving infusion of lymphocytes. Another 20 patients were selected for control group, in which only radiotherapy and chemotherapy were given without lymphocyte infusions. Flow cytometry was used to examine the immunophenotypes and the clinical symptoms were observed before and after treatments. It was found that the numbers of the CD3^ + , CD4^+ cells increased, while those of the CD8 ^+ cells decreased, with an increase of CD4/CD8 radios, but no significant difference existed in case of 22 patients treated with lymphocyte infusion as well as with radiotherapy and chemotherapy. Fifteen patients out of these 22 cases (68.18%), the immunophenotypes changed obviously with increased numbers of CD3^ + , CD4^ + cells in comparison with those before treatment, and the number of CD95^ + cells was increased after treatment. The PS value in this group of patients decreased after treatment. In comparison with 20 cases in the control group, the immunophenotypes showed no differences before and after treatment. While the PS value decreased obviously. Seven out of the 22 cases (31.83 % ) treated with lymphocyte infusions as well as with radiotherapy and chemotherapy illustrated no major changes in their i mmunophenotypes, compared with the situation before treatment, but the PS value also decreased. In case of treatment with lymphocyte infusions in combination with radiotherapy and chemotherapy, the alteration of phenotypes was reversely correlated with the changes of clinical grades. Although there were 7 cases showing no major alterations of the immunological phenotypes, but their correlation was still evident. In the control group, neither alteration of immunophenotypes nor changes in clinical grades was found. It is concluded that immunotherapy in combination with radiotherapy and chemotherapy can relieve the side effects induced by radiotherapy and chemotherapy and also enhance the therapeutic efforts. 展开更多
关键词 Tumor immunotherapy Radiotherapy Chemotherapy immunophenotype Clinical situation
暂未订购
上一页 1 2 82 下一页 到第
使用帮助 返回顶部